Saphar subsidy


In 2012, BIO granted  a € 13,500 subsidy to Saphar, a pharmaceutical products provider in Niger, to support the company in redefining its commercial politics and improve management systems through the SAGE tool. The project was completed successfully.

To learn more on BIO's 2010 investment in Saphar, please visit our project page.

  • Investment amount (€):

    EUR 13,500

  • Contract signature :


  • Nature of intervention :

    Technical assistance subsidy